Scancell Holdings (SCLP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

22.33p
   
  • Change Today:
    -4.17p
  • 52 Week High: 27.00
  • 52 Week Low: 8.54
  • Currency: UK Pounds
  • Shares Issued: 1,037.78m
  • Volume: 5,117,482
  • Market Cap: £231.77m

Latest ShareCast News

/C O R R E C T I O N -- KushoAI/

By PR Newswire

Date: Thursday 02 Apr 2026

(Sharecast News) - Scancell Holdings announced the appointment of David Schilansky as a financial adviser and incoming interim chief financial officer on Thursday, as current CFO Sath Nirmalananthan prepared to step down later this month.

FDA clears Scancell's application for phase three trial

By Josh White

Date: Monday 26 Jan 2026

(Sharecast News) - Scancell said on Monday that the US Food and Drug Administration had cleared its investigational new drug application for a registrational phase three trial of its 'iSCIB1+ Immunobody' in advanced melanoma, paving the way for a global late-stage study planned to begin in 2026.

Scancell reports further data from DNA cancer immunotherapy trial

By Josh White

Date: Tuesday 09 Dec 2025

(Sharecast News) - Scancell reported further positive clinical data for its DNA cancer immunotherapy iSCIB1+, on Tuesday, saying updated phase two results supported its selection for late-stage development in first-line advanced melanoma and reinforce the target patient population.

Scancell reports strong results from Immunobody ... 07-Nov-2025 ShareCast
Scancell narrows loss as it progresses immunothe... 11-Sep-2025 ShareCast
Scancell starts dosing next cohort in melanoma t... 25-Jun-2025 ShareCast
Scancell shares jump on new antibody agreement w... 12-Jun-2024 ShareCast
Scancell appoints healthcare finance veteran as ... 29-Aug-2023 ShareCast
Scancell to present positive recent findings at ... 02-Jun-2023 ShareCast
Scancell shares jump on positive cancer vaccine ... 21-Feb-2023 ShareCast
Scancell licenses Vaccitech IP for its next vacc... 07-Nov-2022 ShareCast
Scancell enrols and doses first patient in lates... 31-Oct-2022 ShareCast
Scancell losses widen on expense of ongoing trials 28-Oct-2022 ShareCast
Scancell inks licensing deal with Nasdaq-traded ... 25-Oct-2022 ShareCast
Scancell presents new, positive data on possible... 23-Sep-2022 ShareCast
Scancell developing 'promising' new cancer treat... 23-Jun-2022 ShareCast
Scancell updates protocol for UK trial in melano... 15-Jun-2022 ShareCast
Scancell opens recruitment for cancer therapy tr... 11-Apr-2022 ShareCast
Scancell treats first patient in melanoma tumour... 19-Nov-2021 ShareCast
Scancell gets MHRA approval for Modi-1 clinical ... 26-Aug-2021 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SCLP Market Data

Currency UK Pounds
Share Price 22.33p
Change Today -4.17p
% Change -15.72 %
52 Week High 27.00
52 Week Low 8.54
Volume 5,117,482
Shares Issued 1,037.78m
Market Cap £231.77m

SCLP Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
19.67% below the market average19.67% below the market average19.67% below the market average19.67% below the market average19.67% below the market average
18.18% above the sector average18.18% above the sector average18.18% above the sector average18.18% above the sector average18.18% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 3
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

SCLP Dividends

No dividends found

Trades for 20-May-2026

Time Volume / Share Price
09:43 125,000 @ 23.04p
10:42 2,770 @ 22.00p
10:41 10,000 @ 22.03p
10:41 500 @ 22.00p
10:41 7 @ 22.50p

SCLP Key Personnel

CFO Sath Nirmalananthan
CEO Phil L'Huillier

Top of Page